Biocon Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	168,274	152,617	147,557	111,742	81,840	71,431
Revenue Growth (YoY)	13.99%	3.43%	32.05%	36.54%	14.57%	13.37%
Cost of Revenue	65,844	60,176	55,822	42,125	31,729	22,437
Gross Profit	102,430	92,441	91,735	69,617	50,111	48,994
Selling, General & Admin	37,574	34,948	28,514	23,321	20,531	17,468
Research & Development	-1,379	-1,476	-838	-3,922	-4,764	-3,507
Other Operating Expenses	30,435	26,638	30,526	23,434	14,611	18,326
Operating Expenses	85,456	77,010	73,901	53,974	38,528	39,455
Operating Income	16,974	15,431	17,834	15,643	11,583	9,539
Interest Expense	-9,615	-8,877	-9,744	-4,190	-676	-577
Interest & Investment Income	1,115	1,115	1,613	1,124	1,121	770
Earnings From Equity Investments	-	-	-842	-1,670	-2,069	-794
Currency Exchange Gain (Loss)	-562	-562	-523	-1,605	579	-89
Other Non Operating Income (Expenses)	1,674	-86	4,288	39	7	94
EBT Excluding Unusual Items	9,586	7,021	12,626	9,341	10,545	8,943
Merger & Restructuring Charges	-	-	-	-470	-	-
Gain (Loss) on Sale of Investments	383	383	2,754	2,596	420	84
Gain (Loss) on Sale of Assets	-76	10,497	-12	-52	-23	1,524
Asset Writedown	-86	-86	-3,945	-	-	-
Other Unusual Items	-2,935	1,051	3,829	-2,444	-1,111	-224
Pretax Income	6,872	18,866	15,252	8,971	9,831	10,677
Income Tax Expense	576	4,572	2,274	2,541	2,115	2,215
Earnings From Continuing Operations	6,296	14,294	12,978	6,430	7,716	8,462
Net Income to Company	6,296	14,294	12,978	6,430	7,716	8,462
Minority Interest in Earnings	-254	-4,161	-2,753	-1,803	-1,232	-1,057
Net Income	6,042	10,133	10,225	4,627	6,484	7,405
Net Income to Common	6,042	10,133	10,225	4,627	6,484	7,405
Net Income Growth	-24.88%	-0.90%	120.99%	-28.64%	-12.44%	-1.03%
Shares Outstanding (Basic)	1,269	1,197	1,195	1,193	1,191	1,187
Shares Outstanding (Diluted)	1,269	1,198	1,197	1,196	1,196	1,197
Shares Change (YoY)	5.94%	0.11%	0.08%	-0.04%	-0.03%	0.80%
EPS (Basic)	4.76	8.46	8.55	3.88	5.44	6.24
EPS (Diluted)	4.76	8.46	8.54	3.87	5.42	6.19
EPS Growth	-29.06%	-0.94%	120.67%	-28.60%	-12.44%	-1.69%
Free Cash Flow	-	19,246	12,734	2,565	-5,212	-3,572
Free Cash Flow Per Share	-	16.06	10.64	2.15	-4.36	-2.98
Dividend Per Share	-	0.500	0.500	1.500	0.500	-
Dividend Growth	-	-	-66.67%	200.00%	-	-
Gross Margin	60.87%	60.57%	62.17%	62.30%	61.23%	68.59%
Operating Margin	10.09%	10.11%	12.09%	14.00%	14.15%	13.35%
Profit Margin	3.59%	6.64%	6.93%	4.14%	7.92%	10.37%
Free Cash Flow Margin	-	12.61%	8.63%	2.30%	-6.37%	-5.00%
EBITDA	33,480	31,239	32,711	26,567	19,564	16,522
EBITDA Margin	19.90%	20.47%	22.17%	23.77%	23.91%	23.13%
D&A For EBITDA	16,506	15,808	14,877	10,924	7,981	6,983
EBIT	16,974	15,431	17,834	15,643	11,583	9,539
EBIT Margin	10.09%	10.11%	12.09%	14.00%	14.15%	13.35%
Effective Tax Rate	8.38%	24.23%	14.91%	28.32%	21.51%	20.75%
Revenue as Reported	171,543	164,699	156,212	115,501	83,967	73,976
Advertising Expenses	-	3,309	1,870	1,482	1,692	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.